• Media Centre
  • Investor relations
  • Client area
  • Client area
  • Stewardship policy
  • Annual reports service

Form of Proxy

CELLECTIS SA

Notes

No. Proposition For Against Abstain
1

APPROVAL OF THE COMPANY FINANCIAL STATEMENTS FOR THE FISCAL YEAR ENDED ON 31 DECEMBER 2024

2

APPROVAL OF THE CONSOLIDATED FINANCIAL STATEMENTS FOR THE FISCAL YEAR ENDED ON 31 DECEMBER 2024

3

ALLOCATION OF THE RESULT FOR FISCAL YEAR ENDED ON 31 DECEMBER 2024

4

ALLOCATION OF LOSSES RECORDED IN THE NRETAINED EARNINGSN ACCOUNT TO NSHARE PREMIUMSN ACCOUNT

5

EXAMINATION OF THE AGREEMENTS REFERRED TO IN ARTICLE L.225-38 ET SEQ. OF THE FRENCH COMMERCIAL CODE (FINANCING CONTRACT CONCLUDED WITH BPIFRANCE)

6

RENEWAL OF THE TERM OF OFFICE OF MR DONALD BERGSTROM AS DIRECTOR

7

APPOINTMENT OF A NEW DIRECTOR (MR ANDRE MULLER)

8

AUTHORIZATION TO BE GRANTED TO THE BOARD OF DIRECTORS TO CARRY OUT THE BUY-BACK OF THE COMPANYNS SHARES

9

AUTHORIZATION TO BE GRANTED TO THE BOARD OF DIRECTORS TO REDUCE THE SHARE CAPITAL BY CANCELLING SHARES UNDER THE AUTHORIZATION THE COMPANY TO BUY BACK ITS OWN SHARES

10

DELEGATION OF AUTHORITY TO THE BOARD OF DIRECTORS TO INCREASE THE SHARE CAPITAL BY THE ISSUE OF ORDINARY SHARES AND/OR ANY OTHER SECURITIES, WITHOUT SHAREHOLDERS PREFERENTIAL SUBSCRIPTION RIGHTS, IN FAVOUR OF A SPECIFIC CATEGORY OF PERSONS (INVESTORS EXPERIENCED IN THE HEALTH OR BIOTECHNOLOGIES SECTOR)

11

DELEGATION OF AUTHORITY TO THE BOARD OF DIRECTORS TO INCREASE THE SHARE CAPITAL BY THE ISSUE OF ORDINARY SHARES AND/OR ANY OTHER SECURITIES, WITHOUT SHAREHOLDERS PREFERENTIAL SUBSCRIPTION RIGHTS, IN FAVOUR OF A CATEGORY OF PERSONS MEETING SPECIFIED CHARACTERISTICS (CREDIT INSTITUTION, INVESTMENT SERVICES, OR MEMBER OF A PLACEMENT SYNDICATE GUARANTEEING THE COMPLETION OF THE CONSIDERED ISSUE

12

DELEGATION OF AUTHORITY TO THE BOARD OF DIRECTORS TO INCREASE THE SHARE CAPITAL BY THE ISSUE OF ORDINARY SHARES AND/OR ANY OTHER SECURITIES, WITHOUT SHAREHOLDERS PREFERENTIAL SUBSCRIPTION RIGHTS, IN FAVOUR OF A CATEGORY OF PERSONS MEETING SPECIFIED CHARACTERISTICS (INDUSTRIAL COMPANIES, INSTITUTIONS OR ENTITIES ACTIVE IN THE HEALTH OR BIOTECHNOLOGIES SECTOR)

13

DELEGATION OF AUTHORITY TO BE GRANTED TO THE BOARD OF DIRECTORS TO INCREASE THE CAPITAL BY ISSUING ORDINARY SHARES OR ANY SECURITIES WITHOUT SHAREHOLDERS PREFERENTIAL SUBSCRIPTION RIGHTS IN FAVOR OF A CATEGORY OF PERSONS MEETING SPECIFIED CHARACTERISTICS WITHIN THE FRAMEWORK OF AN EQUITY OR BOND FINANCING CONTRACT

14

DELEGATION OF AUTHORITY TO BE GRANTED TO THE BOARD OF DIRECTORS TO INCREASE THE SHARE CAPITAL BY THE ISSUE OF ORDINARY SHARES AND/OR SECURITIES, WITH SHAREHOLDERSN PREFERENTIAL SUBSCRIPTION RIGHT MAINTAINED

15

DELEGATION OF AUTHORITY TO BE GRANTED TO THE BOARD OF DIRECTORS TO INCREASE THE SHARE CAPITAL BY THE ISSUE OF ORDINARY SHARES AND/OR SECURITIES, WITHOUT SHAREHOLDERS PREFERENTIAL SUBSCRIPTION RIGHTS BY A PUBLIC OFFER (OTHER THAN THOSE REFERRED TO IN 1 OF ARTICLE L.411-2 OF THE MONETARY AND FINANCIAL CODE

16

DELEGATION OF AUTHORITY TO BE GRANTED TO THE BOARD OF DIRECTORS TO INCREASE THE SHARE CAPITAL BY THE ISSUE OF ORDINARY SHARES AND/OR SECURITIES, WITHOUT SHAREHOLDERS PREFERENTIAL SUBSCRIPTION RIGHTS AS PART OF AN OFFER REFERRED TO IN 1 OF ARTICLE L.411-2 OF THE MONETARY AND FINANCIAL CODE

17

DELEGATION TO THE BOARD OF DIRECTORS TO INCREASE THE NUMBER OF EQUITY SECURITIES TO BE ISSUED, IN THE EVENT OF A SHARE CAPITAL INCREASE, WITH OR WITHOUT PREFERENTIAL SUBSCRIPTION RIGHTS

18

OVERALL LIMITATION OF THE SHARE CAPITAL INCREASES THAT MAY BE CARRIED OUT UNDER THE TENTH RESOLUTION TO THE SEVENTEENTH RESOLUTION MENTIONED ABOVE

19

DELEGATION OF AUTHORITY TO BE GRANTED TO THE BOARD OF DIRECTORS TO INCREASE THE SHARE CAPITAL BY CAPITALIZING OF PREMIUMS, RESERVES, BENEFITS, OR OTHER AMOUNTS

20

AUTHORISATION TO BE GRANTED TO THE BOARD OF DIRECTOR TO GRANT SHARE SUSBCRIPTION OR PURCHASE OPTIONS OF THE COMPANY, AUTOMATICALLY ENTAILING THE WAIVER BY SHAREHOLDERS OF THEIR PREFERENTIAL SUBSCRIPTION RIGHTS

21

AUTHORIZATION TO BE GRANTED TO THE BOARD OF DIRECTORS TO PROCEED WITH FREE ALLOCATIONS OF ORDINARY SHARES OF THE COMPANY, IN FAVOUR OF EMPLOYEES AND/OR CORPORATE OFFICERS OF THE COMPANY AND ITS SUBSIDIARIES, WITHOUT SHAREHOLDERS PREFERENTIAL SUBSCRIPTION RIGHTS

22

DELEGATION OF AUTHORITY TO BE GRANTED TO THE BOARD OF DIRECTORS TO ALLOCATE SUBSCRIPTION WARRANTS GIVING THE RIGHT TO SUBSCRIBE TO ORDINARY SHARES OF THE COMPANY - WITHOUT SHAREHOLDERS PREFERENTIAL SUBSCRIPTION RIGHTS IN FAVOR OF A CATEGORY OF PERSONS MEETING CERTAIN CHARACTERISTICS (PERSONS BOUND BY A SERVICE OR CONSULTING CONTRACT WITH THE COMPANY OR ONE OF ITS SUBSIDIARIES)

23

OVERALL LIMITATION OF SHARES CAPITAL INCREASES THAT MAY BE CARRIED OUT UNDER THE AUTHORIZATION FOR GRANTING SHARE SUSBCRIPTION OR PURCHASE OPTIONS AND THE AUTHORIZATION TO PROCEED WITH THE AUTHORIZATION THE FREE ALLOCATION OF THE ABOVE SHARES

24

DELEGATION OF AUTHORITY TO BE GRANTED TO THE BOARD OF DIRECTORS TO PROCEED WITH A SHARE CAPITAL INCREASE, THE SUBSCRIPTION OF WHICH WOULD BE RESERVED FOR MEMBERS OF A COMPANY SAVINGS PLAN ESTABLISHED IN ACCORDANCE WITH ARTICLES L. 3332-1 AND FOLLOWING OF THE LABOR CODE

25

AMENDMENT OF ARTICLE 12 OF THE STATUTES MEETING OF THE BOARD OF DIRECTORSN

26

AMENDMENT OF ARTICLE 18 OF THE STATUTE RELATING TO GENERAL MEETINGS